id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-E-0584-0007,FDA,FDA-2009-E-0584,U.S. Patent and Trademark Office to Bausch & Lomb Inc. - Letter,Other,Letter(s),2012-06-13T04:00:00Z,2012,6,2012-06-13T04:00:00Z,,2012-06-13T12:44:14Z,,0,0,09000064810428e2
FDA-2009-E-0584-0006,FDA,FDA-2009-E-0584,FDA/CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2011-08-05T04:00:00Z,2011,8,2011-08-05T04:00:00Z,,2011-08-05T16:00:26Z,,0,0,0900006480ed8743
FDA-2009-E-0584-0005,FDA,FDA-2009-E-0584,Determination of Regulatory Review Period for Purposes of Patent Extension: Besivance,Notice,N-Notice,2010-12-06T05:00:00Z,2010,12,2010-12-06T05:00:00Z,,2010-12-08T16:21:28Z,2010-30510,0,0,0900006480baff29
FDA-2009-E-0584-0004,FDA,FDA-2009-E-0584,FDA/CDER to U.S. Patent Trademark Office - Letter,Other,LET-Letter,2010-10-28T04:00:00Z,2010,10,2010-10-28T04:00:00Z,,2010-10-28T19:40:00Z,,0,0,0900006480b79edf
FDA-2009-E-0584-0003,FDA,FDA-2009-E-0584,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-05-11T04:00:00Z,2010,5,2010-05-11T04:00:00Z,,2013-07-27T23:18:42Z,,0,0,0900006480aeb5cc
FDA-2009-E-0584-0001,FDA,FDA-2009-E-0584,U.S. Patent and Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2009-12-08T05:00:00Z,2009,12,,,2013-07-27T23:01:45Z,,0,0,0900006480a6685e
FDA-2009-E-0584-0002,FDA,FDA-2009-E-0584,Bausch & Lomb Inc. - Patent Extension Application,Other,APP-Application,2009-12-08T05:00:00Z,2009,12,,,2013-07-27T23:01:46Z,,0,0,0900006480a66860